Skip to content

Islamic Trauma Healing: Feasibility Study

Islamic Trauma Healing: Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03761732
Enrollment
28
Registered
2018-12-03
Start date
2018-10-15
Completion date
2019-02-06
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Traumatic Stress Disorder

Brief summary

This study will examine the initial feasibility of a program called Islamic Trauma Healing by conducting a small feasibility study (N = 26) of Islamic Trauma Healing in Somalia on key targets of PTSD, depression, somatic symptoms, and quality of life. The hypothesis is that those in Islamic Trauma Healing will show a reduction of PTSD symptoms, depressive symptoms, and somatic symptoms and show improvement in quality of well-being. Feasibility will also be examined by examining at retention, satisfaction, and community feedback.

Detailed description

Islamic Trauma Healing is a lay-led, small-group intervention specifically targeting healing mental wounds of trauma within mosques. The six-session intervention combines empirically supported exposure-based and cognitive restructuring techniques with Islamic principles. A lay-led, group program promotes community building, acknowledges trauma's impact in the community, and facilitates wider implementation. The program is not referred to as therapy or treatment for mental illness. It incorporates community building (e.g., shared tea, supplication), integrated Islamic principles that utilize cognitive restructuring through discussion of prophet narratives (e.g., faith during hard times, Prophet Job \[Ayyub\]), and exposure therapy through individual prayer, talking to Allah about the trauma. Ultimately, the program will follow a self-sustaining train-the-trainer model, led by group leaders, empowering lay leaders to facilitate healing in their communities. Further, training time is dramatically reduced to two, 4-hour training sessions, focusing on teaching skills of group discussion leading rather than training as a lay therapist or mental health counselor. Preliminary data from a community sample and from initial men's and women's groups show a strong perceived need and match with the Islamic faith, with large effects obtained for pre- to post-group across measures (g = 0.76-3.22). Qualitative analysis identified the intervention as operating on potential mechanisms of connectedness to the community, faith integration, healing, and growth. The preliminary data point to the program being well-received and offering a promising model for delivery of a trauma-focused intervention to Muslim communities. The next steps are examining Islamic Trauma Healing in low and moderate-income Muslim countries, examining the feasibility of implementing this lay-led program.

Interventions

6 session behavioral intervention program designed to reduce PTSD and related symptomatology

Sponsors

Case Western Reserve University
CollaboratorOTHER
Seattle Pacific University
CollaboratorOTHER
University of Washington
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This is an active intervention feasibility study, using a pre-post clinical trial design; there is no randomization and no control intervention.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Experienced a DSM-5 trauma at least 12 weeks ago * Report current re-experiencing or avoidance symptoms * Islamic faith * 18-65 year of age

Exclusion criteria

* Immediate suicide risk, with intent or plan * Cannot understand consent/visible cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
PTSD Scale - Self-Report for DSM-5 (PDS-5; Foa et al., 2016)Last 1 WeekPTSD symptoms will be measured using the PTSD Scale - Self-Report for DSM-5 (PDS-5; Foa et al., 2016). Twenty items comprise the PTSD severity scale, with scores ranging from 0 to 80 and higher scores indicating higher PTSD severity. A total score is calculated.

Secondary

MeasureTime frameDescription
Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001)Last 1 WeekThe PHQ-9 is a self-report measure of depression symptoms with each question rated from 0-3. Higher scores indicate greater depression severity, with scores ranging from 0 to 27.
Somatic Symptoms Scale-8 (SSS-8; Gierk et al., 2014)Last 1 WeekThe Somatic Symptoms Scale is an 8 item version of the PHQ-15; self-report assessment of somatic symptoms (e.g., stomach pain, headaches, dizziness). The current version scored items on the original PHQ-15 scale from 0 to 2, with a range from 0 to 16.
Quality of Well-being IndexLast 1 WeekThe WHO-5 Wellbeing Index (WHO-5; Bech, Olsen, Kjoller, & Rasmussen, 2003) will be used to measure well-being. This five-item measure assesses emotional well-being on a 0-5 scale, with higher scores reflecting better well-being. Range of scores is from 0 to 25.

Countries

Somalia

Participant flow

Participants by arm

ArmCount
PTSD Lay-led Group Treatment Program
The group will go through the Islamic Trauma Healing Program Islamic Trauma Healing: 6 session behavioral intervention program designed to reduce PTSD and related symptomatology
26
Total26

Baseline characteristics

CharacteristicPTSD Lay-led Group Treatment Program
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
26 Participants
Depression Symptoms (PHQ-9)10.42 score on a scale
STANDARD_DEVIATION 4.69
PTSD Severity (PDS-5)30.88 score on a scale
STANDARD_DEVIATION 13.76
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
26 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
Somalia
26 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
12 Participants
Somatic Symptoms (SSS-8)8.46 score on a scale
STANDARD_DEVIATION 2.53
Well-Being (WHO-5)10.00 score on a scale
STANDARD_DEVIATION 6.62

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 26
other
Total, other adverse events
0 / 26
serious
Total, serious adverse events
0 / 26

Outcome results

Primary

PTSD Scale - Self-Report for DSM-5 (PDS-5; Foa et al., 2016)

PTSD symptoms will be measured using the PTSD Scale - Self-Report for DSM-5 (PDS-5; Foa et al., 2016). Twenty items comprise the PTSD severity scale, with scores ranging from 0 to 80 and higher scores indicating higher PTSD severity. A total score is calculated.

Time frame: Last 1 Week

ArmMeasureValue (MEAN)Dispersion
PTSD Lay-led Group Treatment ProgramPTSD Scale - Self-Report for DSM-5 (PDS-5; Foa et al., 2016)8.08 score on a scaleStandard Deviation 5.74
Secondary

Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001)

The PHQ-9 is a self-report measure of depression symptoms with each question rated from 0-3. Higher scores indicate greater depression severity, with scores ranging from 0 to 27.

Time frame: Last 1 Week

ArmMeasureValue (MEAN)Dispersion
PTSD Lay-led Group Treatment ProgramPatient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001)2.50 score on scaleStandard Deviation 1.5
Secondary

Quality of Well-being Index

The WHO-5 Wellbeing Index (WHO-5; Bech, Olsen, Kjoller, & Rasmussen, 2003) will be used to measure well-being. This five-item measure assesses emotional well-being on a 0-5 scale, with higher scores reflecting better well-being. Range of scores is from 0 to 25.

Time frame: Last 1 Week

ArmMeasureValue (MEAN)Dispersion
PTSD Lay-led Group Treatment ProgramQuality of Well-being Index19.38 score on a scaleStandard Deviation 2.48
Secondary

Somatic Symptoms Scale-8 (SSS-8; Gierk et al., 2014)

The Somatic Symptoms Scale is an 8 item version of the PHQ-15; self-report assessment of somatic symptoms (e.g., stomach pain, headaches, dizziness). The current version scored items on the original PHQ-15 scale from 0 to 2, with a range from 0 to 16.

Time frame: Last 1 Week

ArmMeasureValue (MEAN)Dispersion
PTSD Lay-led Group Treatment ProgramSomatic Symptoms Scale-8 (SSS-8; Gierk et al., 2014)2.38 score on a scaleStandard Deviation 1.58

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026